Oncocyte Corp. (OCX)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
3 |
$7,167,687 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
15 Apr 2024 |
BROADWOOD PARTNERS, L.P. |
10% |
11 Apr 2024 |
2,420,000 |
2.92 |
7,057,688 |
15 Apr 2024 |
RIGGS JOSH |
CEO and President |
11 Apr 2024 |
3,390 |
2.95 |
10,000 |
15 Apr 2024 |
ARNO ANDREW |
Director |
11 Apr 2024 |
33,898 |
2.95 |
99,999 |
15 Jun 2023 |
KINGSLEY ALFRED D |
Director |
14 Jun 2023 |
30,000 |
0.21 |
6,447 |
07 Apr 2023 |
PURA VIDA INVESTMENTS, LLC |
10% |
05 Apr 2023 |
663,000 |
0.30 |
200,027 |
05 Apr 2023 |
BROADWOOD PARTNERS, L.P. |
10% |
03 Apr 2023 |
26,827,638 |
0.30 |
8,093,898 |
28 Dec 2022 |
ARNO ANDREW |
Director |
23 Dec 2022 |
250,000 |
0.35 |
87,875 |
28 Dec 2022 |
GUTFREUND JOHN PETER |
Director |
23 Dec 2022 |
75,000 |
0.33 |
24,728 |
27 Dec 2022 |
KINGSLEY ALFRED D |
Director |
22 Dec 2022 |
25,000 |
0.28 |
7,125 |
19 Aug 2022 |
LAST ANDREW J. |
Director |
17 Aug 2022 |
20,000 |
0.87 |
17,400 |
19 Aug 2022 |
ARNO ANDREW |
Director |
17 Aug 2022 |
7,500 |
0.90 |
6,750 |
18 Aug 2022 |
ANDREWS RONALD ASBURY |
President & CEO |
16 Aug 2022 |
40,000 |
0.96 |
38,400 |
17 Aug 2022 |
KINGSLEY ALFRED D |
Director |
15 Aug 2022 |
5,000 |
0.97 |
4,850 |
17 Aug 2022 |
GUTFREUND JOHN PETER |
Director |
15 Aug 2022 |
25,000 |
0.93 |
23,250 |
17 Aug 2022 |
GRIFFITH MELINDA |
Director |
16 Aug 2022 |
10,000 |
1.00 |
10,000 |
17 Aug 2022 |
CARTER JENNIFER L. |
Director |
16 Aug 2022 |
10,500 |
0.95 |
9,975 |
17 Aug 2022 |
ARNO ANDREW |
Director |
16 Aug 2022 |
115,523 |
0.97 |
112,057 |
17 Aug 2022 |
ARNO ANDREW |
Director |
15 Aug 2022 |
34,477 |
0.93 |
32,064 |
18 Apr 2022 |
PURA VIDA INVESTMENTS, LLC |
10% |
14 Apr 2022 |
19,210 |
1.23 |
23,571 |
18 Apr 2022 |
PURA VIDA INVESTMENTS, LLC |
10% |
14 Apr 2022 |
1,381,438 |
1.33 |
1,840,766 |
18 Apr 2022 |
PURA VIDA INVESTMENTS, LLC |
10% |
14 Apr 2022 |
92,370 |
1.26 |
116,386 |
18 Apr 2022 |
PURA VIDA INVESTMENTS, LLC |
10% |
14 Apr 2022 |
57,630 |
1.26 |
72,614 |
18 Apr 2022 |
PURA VIDA INVESTMENTS, LLC |
10% |
14 Apr 2022 |
1,665,898 |
1.33 |
2,219,809 |
18 Apr 2022 |
PURA VIDA INVESTMENTS, LLC |
10% |
14 Apr 2022 |
1,916,419 |
1.33 |
2,553,628 |
18 Apr 2022 |
PURA VIDA INVESTMENTS, LLC |
10% |
14 Apr 2022 |
767,952 |
1.33 |
1,023,296 |
18 Apr 2022 |
PURA VIDA INVESTMENTS, LLC |
10% |
14 Apr 2022 |
30,790 |
1.23 |
37,779 |
15 Apr 2022 |
BROADWOOD PARTNERS, L.P. |
10% |
14 Apr 2022 |
6,003,752 |
1.33 |
8,000,000 |
28 Mar 2022 |
ROSS DOUGLAS T. |
Chief Scientific Officer |
25 Mar 2022 |
15,000 |
1.40 |
21,000 |
17 Mar 2022 |
PAULSEN GISELA |
Chief Operating Officer |
17 Mar 2022 |
16,500 |
1.20 |
19,767 |
17 Mar 2022 |
ANDREWS RONALD ASBURY |
Chief Executive Officer |
16 Mar 2022 |
50,000 |
1.28 |
64,150 |
16 Mar 2022 |
REDMOND CAVAN M. |
Director |
16 Mar 2022 |
40,000 |
1.19 |
47,560 |
15 Mar 2022 |
LEVINE MITCHELL S |
Chief Financial Officer |
15 Mar 2022 |
25,000 |
1.17 |
29,150 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock